HEADER TRANSCRIPTION/DNA 01-NOV-07 2JX1 TITLE STRUCTURE OF THE FIFTH ZINC FINGER OF MYELIN TRANSCRIPTION FACTOR 1 IN TITLE 2 COMPLEX WITH RARE DNA COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA (5'- COMPND 3 D(*DAP*DCP*DCP*DGP*DAP*DAP*DAP*DGP*DTP*DTP*DCP*DAP*DC)-3'); COMPND 4 CHAIN: B; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: DNA (5'- COMPND 8 D(*DGP*DTP*DGP*DAP*DAP*DCP*DTP*DTP*DTP*DCP*DGP*DGP*DT)-3'); COMPND 9 CHAIN: C; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: MYELIN TRANSCRIPTION FACTOR 1; COMPND 13 CHAIN: A; COMPND 14 FRAGMENT: THE FIFTH ZINC FINGER DOMAIN; COMPND 15 SYNONYM: MYT1, NEURAL ZINC FINGER FACTOR 2, NZF-2; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 SYNTHETIC: YES; SOURCE 5 MOL_ID: 3; SOURCE 6 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 7 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 8 ORGANISM_TAXID: 10090; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 13 EXPRESSION_SYSTEM_VECTOR: PGEX KEYWDS PROTEIN-DNA COMPLEX, TRANSCRIPTION-DNA COMPLEX EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR R.GAMSJAEGER,M.K.SWANTON,F.J.KOBUS,E.LEHTOMAKI,J.A.LOWRY,A.H.KWAN, AUTHOR 2 J.M.MATTHEWS,J.P.MACKAY REVDAT 3 16-MAR-22 2JX1 1 REMARK REVDAT 2 24-FEB-09 2JX1 1 VERSN REVDAT 1 11-DEC-07 2JX1 0 JRNL AUTH R.GAMSJAEGER,M.K.SWANTON,F.J.KOBUS,E.LEHTOMAKI,J.A.LOWRY, JRNL AUTH 2 A.H.KWAN,J.M.MATTHEWS,J.P.MACKAY JRNL TITL STRUCTURE OF THE FIFTH ZINC FINGER OF MYELIN TRANSCRIPTION JRNL TITL 2 FACTOR 1 IN COMPLEX WITH RARE DNA JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE REMARK 3 -KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ,RICE, REMARK 3 SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SIMULATED ANNEALING, WATER REFINEMENT REMARK 4 REMARK 4 2JX1 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1000100397. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 278 REMARK 210 PH : 7.4; 6.5 REMARK 210 IONIC STRENGTH : 50; 10 REMARK 210 PRESSURE : 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 10MM PHOSPHATE, 50MM SODIUM REMARK 210 CHLORIDE, 1MM DTT, 100% H2O; REMARK 210 2.5MM MES, 10MM SODIUM CHLORIDE, REMARK 210 1MM DTT, 100% H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 2D TOCSY; 3D 15N REMARK 210 -SEPARATED NOESY; 3D HNHA; 2D REMARK 210 HSQC; 3D HNCA; 3D HNCACB; 3D REMARK 210 CBCA(CO)NH; 3D HNCO; 3D HCCH- REMARK 210 TOCSY; 2D SINGLE & DOUBLE HALF REMARK 210 FILTERED NOESYS REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : DRX; AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : HADDOCK DOCKING, SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 10 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O2 DC B 2 H22 DG C 25 0.96 REMARK 500 O2 DC B 3 H22 DG C 24 0.96 REMARK 500 O2 DC B 2 N2 DG C 25 1.97 REMARK 500 O2 DC B 3 N2 DG C 24 1.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 2 LEU A 33 40.02 -83.82 REMARK 500 5 SER A 34 85.48 -64.97 REMARK 500 7 SER A 34 69.21 -117.68 REMARK 500 8 LYS A 11 147.26 -170.83 REMARK 500 9 SER A 32 -165.94 -168.49 REMARK 500 10 SER A 34 79.36 -119.07 REMARK 500 REMARK 500 REMARK: NULL DBREF 2JX1 A 9 39 UNP Q8CFC2 MYT1_MOUSE 843 873 DBREF 2JX1 B 1 13 PDB 2JX1 2JX1 1 13 DBREF 2JX1 C 14 26 PDB 2JX1 2JX1 14 26 SEQRES 1 B 13 DA DC DC DG DA DA DA DG DT DT DC DA DC SEQRES 1 C 13 DG DT DG DA DA DC DT DT DT DC DG DG DT SEQRES 1 A 31 ASP LEU LYS CYS PRO THR PRO GLY CYS ASP GLY SER GLY SEQRES 2 A 31 HIS ILE THR GLY ASN TYR ALA SER HIS ARG SER LEU SER SEQRES 3 A 31 GLY CYS PRO ARG ALA CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1